Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
Eric S. Weiss(University of Pittsburgh), Scott Canna(Children's Hospital of Philadelphia), Stephan Ehl(University Medical Center Freiburg), Dirk Foell(Klinik für Schlafmedizin), Tomoaki Hoshino(Kurume University), Adriana A. de Jesus(National Institute of Allergy and Infectious Diseases), Raphaela Goldbach‐Mansky(National Institutes of Health), Zeshan Tariq(Harvard University), Jennifer Picarsic(University of Pittsburgh), Sandra Ammann(University of Freiburg), Charlotte Girard(University of Geneva), Dirk Holzinger(University of Duisburg-Essen), Cem Gabay(Hôpital Beau-Séjour), Eduardo J. Schiffrin(AB2 Bio (Switzerland)), Alexei A. Grom(Cincinnati Children's Hospital Medical Center)
Cited by 402
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Interleukin-6 and chronic inflammation.
|Arthritis Research & Therapy|2006|1.4k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902